GANX

GAIN THERAPEUTICS INC

GANX·36269B105·US·Common Stock·Healthcare - Biotechnology

GANX (GAIN THERAPEUTICS INC) is held by 28 institutional investors as of Q1 2026. Largest holders: MARSHALL WACE, LLP ($3.4M), JONES FINANCIAL COMPANIES LLLP ($1.2M), GEODE CAPITAL MANAGEMENT, LLC ($868,527). Net institutional sentiment: Mixed.

28
Holders
Avg rating(7 Elite)
$10.5M
Total Value
45% (39)
Fund Consensus
15 buying - 18 selling

No verdict yet — fewer than 2 funds hold GANX.

13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
1.8M(+6.5%)$3.4M0.0%-38.39%
28
Decreased
631,615(-10.1%)$1.2M0.0%-9.06%
0
Increased
447,342(+12.4%)$868,5270.0%-37.88%
28
Decreased
431,267(-37.0%)$836,6580.0%-38.61%
0
New
399,886$775,7790.0%-31.56%
38
New
229,979$446,1590.0%-31.56%
33
Increased
225,046(+7.4%)$436,5890.0%-29.13%
18
Increased
220,489(+171.8%)$427,7490.0%-24.31%
39
Decreased
216,883(-10.5%)$420,7530.0%-32.82%
0
Unchanged
160,000$310,4000.0%-40.98%
0
Unchanged
157,537$305,6220.0%-35.49%
0
Decreased
139,652(-5.4%)$270,9250.0%-8.15%
0
Increased
113,997(+11.8%)$221,1540.0%-32.96%
17
Decreased
104,251(-2.2%)$202,2470.0%-40.98%
0
Increased
29,703(+134.2%)$57,6200.0%-35.93%
34
New
24,900$48,3060.0%-31.56%
31
New
24,500$47,5300.0%-31.56%
28
New
18,376$35,6490.0%-31.56%
30
Unchanged
16,900$32,7860.0%-40.98%
0
Unchanged
15,556$28,7790.0%-0.55%
0

Showing 1-20 of 39

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used